Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Australia — Therapeutic Goods Administration

Tracked across 9 events · 83 articles · First seen May 05, 2026 · Last active Sep 23, 2026

Sentiment
1
Attention
4
Events
9
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 0
Regulatory
Impact: The Australia — Therapeutic Goods Administration granted approval for 4DMedical Limited's CT:VQ technology, allowing its commercial deployment in Australia. This regulatory body's decision is crucial for market access.
Jun 29, 2026 · 8 articles
4 0
Business
Impact: The Australia — Therapeutic Goods Administration (TGA) approved orelabrutinib in Australia, making it available as a new treatment option for Mantle Cell Lymphoma.
May 27, 2026 · 6 articles
2 0
Regulatory
Impact: TGA conducted a Pre-Approval Inspection, enabling Cambrex's High Point facility to manufacture APIs for the Australian market.
Jul 20, 2026 · 8 articles
2 10
Business
Impact: The TGA's approval facilitated the commercial use of Idefirix in Australia, marking a regulatory success for the product in the region.
Aug 18, 2026 · 6 articles
4 0
Regulatory
Hundreds of patients in the United States have filed personal injury lawsuits against Novo Nordisk and Eli Lilly and Company, alleging that widely used GLP-1 medications including Ozempic, Wegovy, Mounjaro, Zepbound and Trulicity caused a…
Impact: Australian regulator that required drugmakers to include warnings about a potentially increased NAION risk with certain GLP-1 medicines, adding to the global regulatory pressure on the drugmakers.
Sep 21, 2026 · 20 articles
4 0
Tech
Impact: The Australia — Therapeutic Goods Administration (TGA) is the regulatory body in Australia whose filing was completed for the clinical trial. Its approval is essential for the trial's conduct.
Jun 03, 2026 · 11 articles
4 0
Business
Impact: The Australia — Therapeutic Goods Administration in Australia oversees the Authorized Prescriber Scheme, under which Optimi Health's psilocybin is prescribed and reimbursed, facilitating patient access to psychedelic medicine.
Jun 29, 2026 · 12 articles
4 0
Tech
Impact: The Australian Australia — Therapeutic Goods Administration previously approved REDEMPLO (plozasiran), expanding its global reach.
May 26, 2026 · 6 articles
2 0
Business
May 05, 2026 · 6 articles
Australia ↔ Australia — Therapeutic Goods Administration
Australia ↔ Australia — Therapeutic Goods Administration
ERGEN INTELLIGENCE
Track Australia — Therapeutic Goods Administration live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.